CENTESSA
LIVE

Serial Number

90872691

Owner

Centessa Pharmaceuticals plc

Attorney

Brandon P. Leahy

Filing Date

Aug 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CENTESSA Trademark

Serial Number: 90872691

CENTESSA is a trademark filed by Centessa Pharmaceuticals plc on August 9, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Centessa Pharmaceuticals plc

3rd Floor 1 Ashley Road, Altrincham
Cheshire WA142DT , GB

Entity Type: 99

Trademark Details

Filing Date

August 9, 2021

Registration Date

Not Registered

Published for Opposition

December 17, 2024

Goods & Services

Pharmaceutical products, preparations, and medicines for the treatment or prevention of hemophilia, tumors, hypertension, narcolepsy, inflammatory diseases or disorders, fibrotic diseases or disorders, autoimmune diseases or disorders, respiratory diseases or disorders, cardiovascular diseases or disorders, central nervous system diseases or disorders, immune system diseases or disorders, cancer, intractable diseases of liver, lung, and heart, and endocrinology diseases or disorders

Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development; pharmaceutical research services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Medical laboratories; Scientific and technological services and research and design relating thereto in the field of drug discovery; development of computer hardware and software

Medical services; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultation and counseling services; treatments for orphan diseases of the kidney, including ADPKD (Autosomal dominant polycystic kidney disease); medical services, namely, providing medical therapies for hemophilia; medical services, namely, administration of pharmaceutical treatments for pulmonary arterial hypertension, oncological and autoimmune diseases; medical services, namely, providing medical treatments for narcolepsy; medical services, namely, providing medical treatments for skin disorders

Medical devices, namely, drug delivery devices and devices for delivering nasal spray treatments

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 27, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 27, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 11, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 11, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 11, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 2, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 15, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 15, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 3, 2024 GNFN
FINAL REFUSAL E-MAILED
Jun 3, 2024 GNFR
FINAL REFUSAL WRITTEN
Jun 3, 2024 CNFR
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 6, 2023 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 26, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 28, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 28, 2023 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 28, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 28, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2023 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 10, 2023 CHAN
ASSIGNED TO LIE
Jan 9, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 14, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2022 CNRT
ASSIGNED TO EXAMINER
May 9, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2021 NWOS
NEW APPLICATION ENTERED
Aug 12, 2021 NWAP